Latest Videos |view all videos
New research at Mayo Clinic is bringing hope to hundreds of thousands of Crohn’s disease patients.
Dr. Eric Klee and Mr. Patrick Blackburn present The Analytical Odyssey of the Diagnostic Odyssey.
Mark Frye, M.D., discusses how the Mayo Clinic Depression Center is providing a comprehensive diagnostic assessment and treatment recommendations for patients with treatment resistant depression and bipolar disorder.
James Greenleaf, Ph.D. presents Mechanical Properties of Tissue Measured by Ultrasound Associate with Disease
Mayo Clinic Psychiatrist Mark Frye, M.D., discusses individualized depression treatment and antidepressant induced mania.
Matthew Rank, M.D. presents Stepping Down Asthma Medication: A Health Care Delivery Solution for Over-Treatment?
Mark A. Frye, MD, chair of the Department of Psychiatry and Psychology, discusses the Mayo Clinic Center for Individualized Medicine's Biobank for Bipolar Disorder.
The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer.
Janet E. Olson, Ph.D. and Stephen Thibodeau, Ph.D. present The Mayo Clinic Biobank – What’s in it for you?
Arthur Beyder, M.D., Ph.D. and Gianrico Farrugia, M.D. present Bedside to Bench to Bedside: Individualizing Diagnosis and Therapy for Irritable Bowel Syndrome (IBS).
Richard Sharp, Ph.D. presents The Future of Individualized Medicine: Aligning Patient and Provider Values.
The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.
Arthur Beyder, M.D., Ph.D., and Gianrico Farrugia, M.D., discuss the morbidity, pathophysiology and genetics of irritable bowel syndrome (IBS), a complex genetic disease.
Thomas Moyer, Ph.D., from Mayo Clinic's Department of Laboratory Medicine and Pathology, describes the four basic categories of patients as identified through this test.
Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors.